Collaborators: Professor T. Alexander (publishes as T. Korakianitis) and Professor M.T. Rothman

A multi-disciplinary research team led by Professor Theodosios Alexander (Professor and Chair of Energy Engineering at QMUL, publishes as Theodosios Korakianitis, PI), and Professor Martin T. Rothman of QMUL and Barts and the London NHS Trust (co-PI), have been funded by the Invention for Innovation (i4i) program of the National Institute for Health Research (NIHR) for the feasibility study of a new type of mechanical circulatory support (MCS) device called TURBOCARDIA, to assist patients in stage IV Congestive Heart Failure. This is the second QMUL MCS device under investigation by the same team of investigators. The first MCS device, called PICS, designed to assist patients in stage III CHF, is in the middle of its feasibility study with funding from the Heptagon Fund. The only similarity between the two devices is the specification for implantation with minimally invasive surgery. CHF is the leading killer of humans, progressing from stage I to II to III to IV, and medication for stages III and IV is palliative.